BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11743747)

  • 1. Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.
    Yao D; Zhang F; Yu L; Yang Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2001 Dec; 14(12):1643-53. PubMed ID: 11743747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone.
    Zhang F; Fan PW; Liu X; Shen L; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):53-62. PubMed ID: 10649967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA.
    Fan PW; Bolton JL
    Drug Metab Dispos; 2001 Jun; 29(6):891-6. PubMed ID: 11353759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells).
    Styles JA; Davies A; Davies R; White IN; Smith LL
    Carcinogenesis; 1997 Feb; 18(2):303-13. PubMed ID: 9054622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide.
    Marques MM; Beland FA
    Carcinogenesis; 1997 Oct; 18(10):1949-54. PubMed ID: 9364005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
    Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
    Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes.
    Iverson SL; Shen L; Anlar N; Bolton JL
    Chem Res Toxicol; 1996 Mar; 9(2):492-9. PubMed ID: 8839054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones.
    Yu L; Liu H; Li W; Zhang F; Luckie C; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2004 Jul; 17(7):879-88. PubMed ID: 15257612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the p-alkyl substituent on the isomerization of o-quinones to p-quinone methides: potential bioactivation mechanism for catechols.
    Iverson SL; Hu LQ; Vukomanovic V; Bolton JL
    Chem Res Toxicol; 1995 Jun; 8(4):537-44. PubMed ID: 7548733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of o-quinone/quinone methide metabolites of quercetin in a cellular in vitro system.
    Awad HM; Boersma MG; Boeren S; van der Woude H; van Zanden J; van Bladeren PJ; Vervoort J; Rietjens IM
    FEBS Lett; 2002 Jun; 520(1-3):30-4. PubMed ID: 12044865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells.
    Knabbe C; Zugmaier G; Schmahl M; Dietel M; Lippman ME; Dickson RB
    Am J Clin Oncol; 1991; 14 Suppl 2():S15-20. PubMed ID: 1835818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones.
    Bolton JL; Shen L
    Carcinogenesis; 1996 May; 17(5):925-9. PubMed ID: 8640939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of lower genotoxicity of toremifene compared with tamoxifen.
    Shibutani S; Ravindernath A; Terashima I; Suzuki N; Laxmi YR; Kanno Y; Suzuki M; Apak TI; Sheng JJ; Duffel MW
    Cancer Res; 2001 May; 61(10):3925-31. PubMed ID: 11358807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro.
    Hemminki K; Widlak P; Hou SM
    Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides.
    Liu J; Liu H; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2005 Feb; 18(2):174-82. PubMed ID: 15720121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone.
    Zhang F; Chen Y; Pisha E; Shen L; Xiong Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 1999 Feb; 12(2):204-13. PubMed ID: 10027800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole.
    Bolton JL; Acay NM; Vukomanovic V
    Chem Res Toxicol; 1994; 7(3):443-50. PubMed ID: 8075378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate antiestrogens and approaches to the prevention of breast cancer.
    Jordan VC
    J Cell Biochem Suppl; 1995; 22():51-7. PubMed ID: 8538210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.